Let’s look at the key reasons that are pushing Tempest Therapeutics Inc (TPST) to new highs

MAXR

A new trading day began on Monday, with Tempest Therapeutics Inc (NASDAQ: TPST) stock price up 8.54% from the previous day of trading, before settling in for the closing price of $8.25. TPST’s price has ranged from $5.35 to $42.12 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Meanwhile, its annual earnings per share averaged 48.05%. With a float of $3.37 million, this company’s outstanding shares have now reached $3.52 million.

Let’s determine the extent of company efficiency that accounts for 25 employees. In terms of profitability, gross margin is 18.11%, operating margin of -9256.58%, and the pretax margin is -9217.9%.

Tempest Therapeutics Inc (TPST) Breakdown of a Key Holders of the stock

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tempest Therapeutics Inc is 8.46%, while institutional ownership is 4.28%. The most recent insider transaction that took place on Aug 12 ’24, was worth 426,993. Before that another transaction happened on Aug 08 ’24, when Company’s 10% Owner sold 400,000 for $1.35, making the entire transaction worth $540,040. This insider now owns 597,940 shares in total.

Tempest Therapeutics Inc (TPST) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.59 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 48.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.92% during the next five years compared to 50.16% growth over the previous five years of trading.

Tempest Therapeutics Inc (NASDAQ: TPST) Trading Performance Indicators

Here are Tempest Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.70.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -18.08, a number that is poised to hit -2.61 in the next quarter and is forecasted to reach -10.38 in one year’s time.

Technical Analysis of Tempest Therapeutics Inc (TPST)

Looking closely at Tempest Therapeutics Inc (NASDAQ: TPST), its last 5-days average volume was 0.55 million, which is a jump from its year-to-date volume of 87557.0. As of the previous 9 days, the stock’s Stochastic %D was 65.59%. Additionally, its Average True Range was 0.82.

During the past 100 days, Tempest Therapeutics Inc’s (TPST) raw stochastic average was set at 46.41%, which indicates a significant decrease from 50.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 86.35% in the past 14 days, which was higher than the 82.40% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $7.22, while its 200-day Moving Average is $11.69. However, in the short run, Tempest Therapeutics Inc’s stock first resistance to watch stands at $11.02. Second resistance stands at $13.10. The third major resistance level sits at $14.24. If the price goes on to break the first support level at $7.80, it is likely to go to the next support level at $6.66. Now, if the price goes above the second support level, the third support stands at $4.58.

Tempest Therapeutics Inc (NASDAQ: TPST) Key Stats

With a market capitalization of 32.96 million, the company has a total of 3,682K Shares Outstanding. Currently, annual sales are 0 K while annual income is -41,840 K. The company’s previous quarter sales were 0 K while its latest quarter income was -10,860 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.